The trademark application ASTAXANTIN was filed by Acrilex Egenvård AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). Application refused.
The application was filed in Swedish (English was selected as the second language).
The Refusal with reference B 017892899 was Rejected according to Article 7(1)(b) EUTMR with decision issued on July 15, 2018 by the EUIPO.